Rapid Medical

Rapid MedicalRapid Medical
Rapid Medical

Rapid Medical

Developer of innovative, controllable neurovascular devices for the treatment of ischemic and hemorrhagic stroke.

DR 302008Active151Yokneam Illit, Israel
Rate

About

Rapid Medical develops innovative neurovascular therapy solutions for ischemic and hemorrhagic stroke. Their active technology-driven devices, such as TIGERTRIEVER and COMANECI, are engineered for precise control and adapt to individual patient anatomy, enabling physicians to tailor procedures for improved outcomes. The company serves healthcare professionals involved in stroke intervention.
Frequently asked

What does Rapid Medical do?

Rapid Medical develops innovative neurovascular therapy solutions for ischemic and hemorrhagic stroke. Their active technology-driven devices, such as TIGERTRIEVER and COMANECI, are engineered for precise control and adapt to individual patient anatomy, enabling physicians to tailor procedures for improved outcomes. The company serves healthcare professionals involved in stroke intervention.

What is Rapid Medical's revenue?

StartupHub estimates Rapid Medical's annual revenue at $49.9M (range $26.8M to $65.9M, 65% confidence), based on comparable companies in the sector.

What is Rapid Medical's valuation?

StartupHub estimates Rapid Medical's effective valuation at $291.2M (range $175.0M to $420.0M, 10% confidence), based on comparable companies in the sector.

How much funding has Rapid Medical raised?

Rapid Medical has raised a total of $70M in funding. The most recent round on record is Series D.

Where is Rapid Medical headquartered?

Rapid Medical is headquartered in Yokneam Illit, Israel.

When was Rapid Medical founded?

Rapid Medical was founded in 2008.

What industry does Rapid Medical operate in?

Rapid Medical operates in Medical Devices, Neurovascular, HealthTech.

How many employees does Rapid Medical have?

Rapid Medical has approximately 151 people on record.

HEADCOUNT
151
DOMAIN RATING
30
Comments

No comments yet. Be the first to share your take.